Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Cambridge Respiratory Innovations to become vital player in capnography market, says GlobalData

Following news that Cambridge Respiratory Innovations has teamed with several NHS trusts to supply N-Tidal (capnography) devices in order to help doctors identify when to ventilate COVID-19 patients; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The accelerated production of N-Tidal devices by Cambridge Respiratory Innovations to […]
Read more

Australia’s commitment to invest in vibrant clinical trial ecosystem will benefit medical device industry, says GlobalData

Australia is dedicating more government funding towards the establishment of a vibrant clinical trial ecosystem in order to accelerate the design, development, verification and product launch processes of medical devices, says GlobalData, a leading data and analytics company. An analysis of GlobalData’s Medical Intelligence Center reveals that the Australia’s clinical trials sector is large and […]
Read more

MicroGenDx provides faster turnaround times using first-ever coronavirus saliva test, says GlobalData

Following the announcement that the MicroGenDx has reported fast turnaround times for COVID-19 testing using saliva tests; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “MicroGenDx is the only commercial testing lab using saliva and sputum samples, which perform much better than samples collected by nasopharyngeal swabs. […]
Read more

Non-medical companies respond to mask and ventilator manufacturing appeals amidst shortage, says GlobalData

The overwhelming demand for masks and ventilators is forcing governments across the globe to look for alternate manufacturers, says GlobalData, a leading data and analytics company. As tracked by GlobalData’s news database, companies across alternate industries and geographies have started mask and ventilator production. Several automotive manufacturers have ramped up the production of masks and […]
Read more

AgVa Healthcare best placed to capitalize on growing demand for ventilators in India, says GlobalData

As the number of coronavirus (Covid-19) cases continue to increase in India, AgVa Healthcare with its cost-effective portable ventilator is best placed to capitalize on the growing demand for ventilators across the country, says GlobalData, a leading data and analytics company. GlobalData’s report, ‘India Respiratory Devices Market Outlook to 2025’, reveals that  the ventilator market […]
Read more

Large number of TAVR procedures need to be delayed due to CAIC’s new guidelines for TAVR practice, says GlobalData

Following thenews that the Canadian Association of Interventional Cardiology (CAIC) released new guidelines for cardiology procedures; Ashley Young, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view on the current situation: “The new guidelines for cardiology procedures come as no surprise, as more and more cardiology associations around the world […]
Read more

880,000 global ventilator shortage can only be met by new simple design requiring minimal operator training time, says GlobalData

Ventilator shortages are a critical reality as the COVID-19 outbreak continues to worsen globally. According to GlobalData analysis, around 880,000 more ventilators are in demand globally because of the pandemic. All ventilator manufacturers have full order books and hold little in stock, receiving orders not only from regular customers like hospitals, but also directly from […]
Read more

Digital biomarkers emerging as important predictive tools to support global COVID-19 pandemic, says GlobalData

Remote patient monitoring (RPM) is accelerating the development and validation of digital biomarkers to help identify patients that are at risk from the coronavirus (COVID-19), supporting the assessment of disease progression and allowing continuous monitoring of disease symptoms, as well as providing data for new outbreaks, says GlobalData, a leading data and analytics company. Roxanne Balfe, […]
Read more

Colorectal cancer screening tests market to surpass $2bn by 2028, says GlobalData

National Colorectal Cancer (CRC) Awareness Month is an opportunity to raise awareness and prevent future cases of CRC. Currently, the global market value for in-vitro diagnostics (IVD) tests for CRC screening is estimated at $771.25m. This is expected to increase even more strongly than test volumes, reaching $2bn by 2028 at a compound annual growth rate (CAGR) of 10%, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Colorectal Cancer Screening Tests – In Vitro […]
Read more

Coronavirus pandemic likely to reduce volume of peripheral vascular procedures

The market share for medical devices meant to treat peripheral vascular diseases, including devices such as PTA balloon catheters, stents, atherectomy devices and vascular grafts are expected to suffer due to the coronavirus (COVID-19) pandemic, according to GlobalData, a leading data and analytics company.  The global atherectomy devices market, worth approximately $760m in 2019, may […]
Read more

Sales of N95 respirators in US healthcare institutions doubled between Dec 2019 and Jan 2020, says GlobalData

Heightened demand for N95 respirators means that product counterfeiting, faulty stock, and price gouging are ongoing issues, says GlobalData, a leading data and analytics company. Alison Casey, Medical Device Analyst at GlobalData, comments: “GlobalData estimates that sales of N95 respirators in US healthcare facilities more than doubled between December 2019 and January 2020 to surpass […]
Read more

Rapid diagnostic tests to greatly increase testing capacity for diagnosing COVID-19

There is a current worldwide lack of testing capacity for the novel coronavirus (COVID-19) outbreak. The frontline response for diagnosing COVID-19 has been polymerase chain reaction (PCR) testing. Although PCR is the go-to test for diagnosing an infectious agent, the test protocol is complex and expensive as it is mainly suited to large, centralized diagnostic laboratories, and tests typically take four to six hours to complete, says GlobalData, a leading data and analytics company. The solution to a paucity of testing is rapid point-of-care (POC) tests, […]
Read more
1 … 46 47 48 49 50 51